Indaptus Therapeutics, Inc. (INDP)

Number of records: 5
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
07-Jun-22 8:00 AM
View: 
Meckler Jeffrey A
CEO and Director
Director
Indaptus Therapeutics, Inc. (INDP) 06-Jun-22Private Purchase 19,727$2.63$51,882.0077%
25.65K to 45.37K
02-Feb-22 5:08 PM
View: 
Newman Michael James
CSO and Director
Director
10% Owner
Indaptus Therapeutics, Inc. (INDP) 01-Feb-22Market Sale (Planned) 14,130$5.00$70,692.40(< 1%)
2.76M to 2.75M
(6%)
02-Feb-22 5:08 PM
View: 
Newman Michael James
CSO and Director
Director
10% Owner
Indaptus Therapeutics, Inc. (INDP) 31-Jan-22Market Sale (Planned) 5,870$5.00$29,350.60(< 1%)
2.77M to 2.76M
(6%)
19-Nov-21 9:16 AM
View: 
Meckler Jeffrey A
CEO and Director
Director
Indaptus Therapeutics, Inc. (INDP) 18-Nov-21Market Purchase 11,187$5.82$65,108.3077%
14.46K to 25.65K
16-Sep-21 6:22 PM
View: 
Meckler Jeffrey A
CEO and Director
Director
Indaptus Therapeutics, Inc. (INDP) 14-Sep-21Market Purchase 12,000$7.00$84,000.00488%
2.46K to 14.46K
54%